Patients’ Access to Treatment Act
I got this email today regarding my lobbying efforts in Washington DC earlier in May of this year.
Great news: thanks to advocates like you,there are now 133 Congressional Representatives signed on as co-sponsors of the Patients’ Access to Treatments Act!
That’s a 23 percent increase in support in the two months since our efforts on Advocacy Day – and a huge step toward legislation that could change the lives of cancer patients across the country.
Every day, our elected officials hear from constituents about competing causes. These new co-sponsors received thousands of phone calls and letters from LLS supporters and listened to your personal stories in our face-to-face meetings on Advocacy Day. The sheer passion of our community inspired them to join this movement – to have them standing with us on this issue shows that they’ve made cancer patients a top priority.
This bill is critical for helping blood cancer patients who are struggling with astronomical fees from “specialty tier” drug pricing. Essential medications are out of reach for many who need them to stay alive. The Patients’ Access to Treatments Act would require private health plans to limit patient costs for “specialty tier” drugs, and ensure access to vital cancer medications. Thanks to you, it’s one step closer to becoming a reality.
I want to thank you for standing with us on this issue. Together, we are making a difference for cancer patients and their loved ones.
Chief Policy and Advocacy Officer
The Leukemia & Lymphoma Society
This entry was posted on July 22, 2014 at 5:58 pm and is filed under Uncategorized with tags aca, affordable healthcare act, cancer, cancer treatment, congress, leukemia and lymphoma society, LLS, lobby, lobbying, obamacare, patients' access to treatments act. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.